Atomwise
Pioneer in AI for molecule screening — has predicted activity for hundreds of millions of small molecules.
- Location
- San Francisco, United States
- Raised
- $174M+
- Stage
- Series B
- Founded
- 2012
- Category
- Other
- Funding
- VC-backed
- Team
- 51-200
Funding figures as of Jul 2025 · not independently verified
Founders of Atomwise
- Abraham Heifets
- Izhar Wallach
Investors backing Atomwise
- BV
- B Capital
- DCVC
Frequently asked questions
What does Atomwise do?
Pioneer in AI for molecule screening — has predicted activity for hundreds of millions of small molecules.
Where is Atomwise based?
Atomwise is based in San Francisco, United States.
When was Atomwise founded?
Atomwise was founded in 2012.
How much has Atomwise raised?
Atomwise has raised $174M+ in their Series B round as of Jul 2025.
Who founded Atomwise?
Atomwise was founded by Abraham Heifets, Izhar Wallach.
Who has invested in Atomwise?
Atomwise is backed by BV, B Capital, DCVC.
How Atomwise would pitch themselves
○ Auto-generated01Target customer
Customers in the Atomwise space — typically operators or teams running into the problem this product solves.
02Problem they solve
Pioneer in AI for molecule screening — has predicted activity for hundreds of millions of small molecules. The category has historically been served by tools that miss the modern workflow this product is built around.
03Key differentiator
Atomwise differentiates on ai-powered structure-based drug discovery. Backed by BV + B Capital, $174M+ raised — the company has resources + validation to compound this thesis. Founded by Abraham Heifets + team.
04Go-to-market strategy
Growth-stage GTM — multi-channel revenue motion (direct enterprise sales, channel partnerships, marketplace listings). Vertical specialisation + verticalised AE teams targeting enterprise + mid-market.